ChenGuang Biotech Group Co., Ltd. (300138.SZ)
CNY 10.92
(1.11%)
CNY 10.92
(1.11%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 865 Million CNY | 11.76% |
| 2022 | 774 Million CNY | 153.13% |
| 2021 | 305.77 Million CNY | -70.35% |
| 2020 | 1.03 Billion CNY | 300.41% |
| 2019 | 257.56 Million CNY | 0.0% |
| 2018 | - CNY | 0.0% |
| 2017 | - CNY | 0.0% |
| 2016 | - CNY | 0.0% |
| 2015 | - CNY | -100.0% |
| 2014 | 1.00 CNY | 0.0% |
| 2013 | - CNY | 0.0% |
| 2012 | - CNY | 0.0% |
| 2011 | - CNY | -100.0% |
| 2010 | 2.63 Million CNY | -49.43% |
| 2009 | 5.21 Million CNY | 2.33% |
| 2008 | 5.09 Million CNY | 13.43% |
| 2007 | 4.49 Million CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 1.22 Billion CNY | 36.06% |
| 2024 Q2 | 1.47 Billion CNY | 25.47% |
| 2024 Q3 | 1.33 Billion CNY | -9.89% |
| 2023 Q2 | 273.67 Million CNY | -64.64% |
| 2023 Q1 | 773.98 Million CNY | -0.0% |
| 2023 Q3 | 418.73 Million CNY | 53.01% |
| 2023 Q4 | 865 Million CNY | 106.57% |
| 2023 FY | 865 Million CNY | 11.76% |
| 2022 FY | 774 Million CNY | 153.13% |
| 2022 Q2 | 736.06 Million CNY | 140.59% |
| 2022 Q3 | 772.7 Million CNY | 4.98% |
| 2022 Q4 | 774 Million CNY | 0.17% |
| 2022 Q1 | 305.93 Million CNY | 0.05% |
| 2021 Q3 | 598.72 Million CNY | 0.02% |
| 2021 FY | 305.77 Million CNY | -70.35% |
| 2021 Q2 | 598.59 Million CNY | 0.02% |
| 2021 Q1 | 598.46 Million CNY | -41.97% |
| 2021 Q4 | 305.77 Million CNY | -48.93% |
| 2020 Q2 | 847.06 Million CNY | 228.71% |
| 2020 Q3 | 1.1 Billion CNY | 30.2% |
| 2020 FY | 1.03 Billion CNY | 300.41% |
| 2020 Q4 | 1.03 Billion CNY | -6.49% |
| 2020 Q1 | 257.69 Million CNY | 0.05% |
| 2019 Q2 | 64.44 Million CNY | 0.0% |
| 2019 FY | 257.56 Million CNY | 0.0% |
| 2019 Q3 | 260 Million CNY | 303.43% |
| 2019 Q4 | 257.56 Million CNY | -0.94% |
| 2019 Q1 | - CNY | 0.0% |
| 2018 Q3 | - CNY | 0.0% |
| 2018 Q1 | - CNY | 0.0% |
| 2018 FY | - CNY | 0.0% |
| 2018 Q4 | - CNY | 0.0% |
| 2018 Q2 | - CNY | 0.0% |
| 2017 Q3 | - CNY | 0.0% |
| 2017 Q4 | - CNY | 0.0% |
| 2017 FY | - CNY | 0.0% |
| 2017 Q1 | - CNY | 0.0% |
| 2017 Q2 | - CNY | 0.0% |
| 2016 Q4 | - CNY | 0.0% |
| 2016 Q3 | - CNY | 0.0% |
| 2016 Q2 | - CNY | 0.0% |
| 2016 FY | - CNY | 0.0% |
| 2016 Q1 | - CNY | 0.0% |
| 2015 Q1 | 1.00 CNY | 0.0% |
| 2015 Q3 | - CNY | -100.0% |
| 2015 FY | - CNY | -100.0% |
| 2015 Q4 | - CNY | 0.0% |
| 2015 Q2 | 1.00 CNY | 0.0% |
| 2014 Q2 | - CNY | 0.0% |
| 2014 Q4 | 1.00 CNY | 0.0% |
| 2014 Q3 | - CNY | 0.0% |
| 2014 Q1 | - CNY | 0.0% |
| 2014 FY | 1.00 CNY | 0.0% |
| 2013 Q2 | - CNY | 0.0% |
| 2013 FY | - CNY | 0.0% |
| 2013 Q4 | - CNY | 0.0% |
| 2013 Q3 | - CNY | 0.0% |
| 2013 Q1 | - CNY | 0.0% |
| 2012 Q3 | - CNY | 0.0% |
| 2012 Q4 | - CNY | 0.0% |
| 2012 Q1 | - CNY | 0.0% |
| 2012 FY | - CNY | 0.0% |
| 2012 Q2 | - CNY | 0.0% |
| 2011 Q1 | 2.66 Million CNY | 1.1% |
| 2011 Q2 | 2.69 Million CNY | 1.11% |
| 2011 Q4 | - CNY | -100.0% |
| 2011 FY | - CNY | -100.0% |
| 2011 Q3 | 2.72 Million CNY | 1.1% |
| 2010 Q3 | 5.3 Million CNY | 0.56% |
| 2010 Q4 | 2.63 Million CNY | -50.28% |
| 2010 FY | 2.63 Million CNY | -49.43% |
| 2010 Q2 | 5.27 Million CNY | 0.0% |
| 2009 Q4 | 5.21 Million CNY | 0.0% |
| 2009 FY | 5.21 Million CNY | 2.33% |
| 2008 FY | 5.09 Million CNY | 13.43% |
| 2007 FY | 4.49 Million CNY | 0.0% |